Sorrento Therapeutics Inc (SRNE)

[dia76ca]

An article in May 18 2021 Scientific American asks why Monoclonal Antibodies aren't more widely used to treat Covid? Sorrento has the answers! The article concludes...

"For monoclonals to be more widely distributed, the possibility of administering them subcutaneously or intramuscularly rather than intravenously should be explored. We should also move their administration from the clinic into pharmacies and testing sites where it can be more easily and readily done.
As long as we continue to have cases of COVID, vaccination should not be the only strategy we implement for control. While progress has been made vaccinating high-risk populations in the U.S., we still need to increase access to effective therapies that can prevent disease progression, hospitalization and death among those who get infected with SARS-CoV-2."

Covi-AMG, Covi-Drops and Covi-plasmid DNA are needed now! $34 million DARPA funding shows Defense Department knows what Sorrento has!

'Why Monoclonal Antibody COVID Therapies Have Not Lived Up to Expectations. The drugs used to treat Donald Trump have not been widely administered to other patients, but they still have a role to play"
By Carlos del Rio on May 18, 2021